The Peripheral Directional Atherectomy System Market Size is predicted to witness a 5.82 % CAGR during the forecast period for 2023-2031.
Atherectomy devices eliminate plaque and blood clots from within the arteries. Both peripheral and coronary artery atherosclerosis are addressed using these Peripheral Directional Atherectomy Systems. The accumulation of plaque or blood clots within the arteries leads to the obstruction of normal blood flow. The swift onset of the COVID-19 pandemic resulted in the postponement or cancellation of various elective cardiovascular procedures to minimize the risk of coronavirus transmission during hospital visits. Moreover, the impact on the supply chain was intensified by reduced disposable income.
Nonetheless, a positive influence on the market is anticipated once the pandemic subsides. Continuous progress in the realm of medical device technology has given rise to the creation of a more sophisticated and efficient peripheral directional Atherectomy System. These advancements enhance plaque removal's precision, efficacy, and safety, ultimately improving patient outcomes and expanding the market scope.
However, a shortage of skilled healthcare professionals might soon present additional challenges to the peripheral directional atherectomy system market. Due to pricing considerations, adopting peripheral directional atherectomy procedures, including the associated device costs, could face obstacles. Furthermore, the rising incidence of peripheral arterial diseases will offer potential growth opportunities for the Peripheral Directional Atherectomy System market in the forthcoming years.
Competitive Landscape
Some Major Key Players In The Peripheral Directional Atherectomy System Market:
- Medtronic (Ireland)
- Koninklijke Philips N.V. (Netherlands)
- Cardinal Health. (US)
- Cardiovascular Systems, Inc. (US)
- Boston Scientific Corporation (US)
- Minestrone Medical Inc. (US)
- Avinger(US)
Market Segmentation:
The peripheral directional atherectomy system market is segmented based on end users. The market is segmented based on end-users into hospitals, cardiac centers and ambulatory care centres.
Based On End Users, The Hospital Segment Is A Major Contributor To The Peripheral Directional Atherectomy System Market
The hospital category will hold a major share in the global peripheral directional atherectomy system market 2022. clinical efficacy, patient preferences, technological advancements, and the potential for improved patient outcomes and operational efficiencies drive hospitals' increasing demand for peripheral directional atherectomy systems. Hospitals recognize the value of these systems in addressing peripheral arterial diseases while aligning with their commitment to quality patient care. As awareness about peripheral arterial diseases and available treatment options grows, patients and healthcare professionals are more likely to explore advanced solutions like peripheral directional atherectomy systems. This heightened awareness contributes to the overall demand for these systems.
The North America Peripheral Directional Atherectomy System Market Holds A Significant Regional Share
The North America Peripheral Directional Atherectomy System market is expected to register the highest share. Collaboration between hospitals and medical device manufacturers can drive the development and customization of atherectomy systems that align with specific hospital needs. This collaboration ensures that the systems integrate seamlessly into hospital workflows and patient care pathways, accelerating the growth in this regionIn addition, the Asia Pacific regional market is projected to develop rapidly in the global Peripheral Directional Atherectomy System market. Cultural perceptions of medical treatments and interventions can influence patient and physician preferences. Economic considerations, including healthcare budgets and reimbursement policies, also played a role in adopting new medical technologies.
Peripheral Directional Atherectomy System Market Report Scope
Report Attribute |
Specifications |
Growth Rate CAGR |
CAGR of 5.82 % from 2023 to 2031 |
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2023 to 2031 |
Historic Year |
2019 to 2022 |
Forecast Year |
2023-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By End-Users |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Cardinal Health. (US), Cardiovascular Systems, Inc. (US), Boston Scientific Corporation (US), Minestrone Medical Inc. (US), Avinger (US) |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |